Changing the course of cancer treatment
We harness the power of the body's immune system to keep tumor cells in check without harming health or quality of life.
Mendus AB (publ) announces Q4 and year-end results 2022
“We are very happy with the progress we have made on all fronts in 2022 and the continued commitment of our entire team to develop impactful new cancer therapies. For 2023, we have taken necessary steps to focus on our most value-generating projects...
Publication of Year-end Report 2022
Publication of Annual Report 2022
Annual General Meeting
Publication of Q1 Report
Publication of Q2 Report
Publication of Q3 Report
Publication of Year-end Report 2023
Keep up to date
Join our mailing list to receive our latest news.